Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a system notice about a lapse in government funding and updated page revision from v3.4.0 to v3.4.1, with no changes to trial content or core functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T00:27:43.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Additions: Show glossary; Last Update Submitted that Met QC Criteria; Last Update Posted; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; Last Update Posted (Estimated); No FEAR Act data; Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-27T23:55:45.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The Study Protocol and Statistical Analysis Plan PDF and related study documents were removed from the page.
    Difference
    16%
    Check dated 2026-01-21T00:30:49.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4; no changes to the study details, outcomes, or listed locations.
    Difference
    0.0%
    Check dated 2026-01-14T01:18:43.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Updated the Locations section: added a comprehensive list of state locations with revision v3.3.3 and removed the previous state-specific location entries (revision v3.3.2).
    Difference
    1%
    Check dated 2025-12-23T10:14:30.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Site revision update from v3.3.1 to v3.3.2 with no changes to the study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:42:14.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.